Valneva (VALN) News Today $5.72 -0.09 (-1.62%) As of 07/3/2025 01:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VALN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL SeqirusJune 26, 2025 | globenewswire.comValneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidanceJune 25, 2025 | globenewswire.comValneva Scotland earns prestigious global health and safety awardJune 24, 2025 | msn.comValneva (NASDAQ:VALN) Shares Gap Down - Should You Sell?June 17, 2025 | marketbeat.comValneva SE (NASDAQ:VALN) Sees Large Drop in Short InterestJune 14, 2025 | marketbeat.comValneva (NASDAQ:VALN) Stock Price Down 4% - Here's What HappenedJune 12, 2025 | marketbeat.comUK's MHRA suspends Valneva's chikungunya vaccine for elderlyJune 10, 2025 | reuters.comUK restricts use of Valneva chikungunya vaccine for safety reviewJune 10, 2025 | yahoo.comUK's MHRA suspends Valneva's chikungunya vaccine for elderly (June 9)June 10, 2025 | msn.comValneva reports data from Phase II chikungunya vaccine trial in childrenJune 6, 2025 | finance.yahoo.comValneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®June 5, 2025 | globenewswire.comValneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate UpdateJune 4, 2025 | globenewswire.comValneva (NASDAQ:VALN) Shares Gap Down - Time to Sell?June 3, 2025 | marketbeat.comValneva SE (NASDAQ:VALN) Sees Large Decrease in Short InterestJune 2, 2025 | marketbeat.comValneva to Participate at U.S. and European Investor Conferences in JuneMay 26, 2025 | globenewswire.comUS CDC accepts recommendations for chikungunya vaccinesMay 21, 2025 | msn.comU.S. Advises Older Travelers to Avoid Chikungunya VaccineMay 13, 2025 | usnews.comFDA warns seniors to avoid this vaccine after deadly complicationsMay 13, 2025 | msn.com2VALN : US Health Agencies Recommend Pausing Valneva's Chikungunya Vaccine For...May 13, 2025 | benzinga.comWhat Is the Chikungunya Vaccine? CDC Issues Notice to Older TravelersMay 12, 2025 | msn.comUS health officials advise older travelers not to get a chikungunya vaccineMay 12, 2025 | apnews.comAValneva’s chikungunya vaccine use halted in older adults amid safety concernsMay 12, 2025 | finance.yahoo.comValneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United StatesMay 12, 2025 | globenewswire.comU.S. recommends a pause in Valneva chikungunya vaccine for those over 60May 10, 2025 | msn.comEli Lilly extends Purdue alliance; EMA investigates Valneva shotMay 10, 2025 | finance.yahoo.comValneva SE 2025 Q1 - Results - Earnings Call PresentationMay 8, 2025 | seekingalpha.comValneva SE (INRLF) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Operational ...May 8, 2025 | finance.yahoo.comValneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 GuidanceMay 8, 2025 | seekingalpha.comEurope reviews Valneva's chikungunya vaccine after reports of serious side effectsMay 7, 2025 | msn.comValneva dips as EU suspends use of chikungunya shot in older adultsMay 7, 2025 | msn.comValneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in ElderlyMay 7, 2025 | globenewswire.comEurope reviews Valneva's chikungunya vaccine after reports of serious side-effects in older peopleMay 7, 2025 | reuters.comValneva Reports First Quarter 2025 Financial Results and Provides Corporate UpdatesMay 7, 2025 | globenewswire.com7VALN : Insights Ahead: Valneva's...May 6, 2025 | benzinga.comHealth Secretary tours company's state-of-the-art manufacturing facility in LivingstonMay 5, 2025 | msn.comValneva (NASDAQ:VALN) Sees Unusually-High Trading Volume - Here's What HappenedMay 5, 2025 | marketbeat.comHealth Secretary tours site of Scotland’s largest vaccine producerMay 2, 2025 | msn.comValneva (NASDAQ:VALN) Shares Down 3.6% - Here's What HappenedMay 1, 2025 | marketbeat.comValneva (VALN) Expected to Announce Earnings on TuesdayMay 1, 2025 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Down - What's Next?April 30, 2025 | marketbeat.comShort Interest in Valneva SE (NASDAQ:VALN) Drops By 49.2%April 29, 2025 | marketbeat.comFrance halts Valneva’s chikungunya vaccine use in seniorsApril 28, 2025 | finance.yahoo.comValneva Shares Slump After France Suspends Chikungunya Vaccine for ElderlyApril 28, 2025 | marketwatch.comIn a world first, Brazil approves chikungunya vaccineApril 27, 2025 | msn.comValneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French AuthoritiesApril 26, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNApril 25, 2025 | globenewswire.comValneva (NASDAQ:VALN) Shares Gap Up - Still a Buy?April 24, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNApril 22, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNApril 21, 2025 | globenewswire.comValneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. TravelersApril 18, 2025 | globenewswire.com Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address VALN Media Mentions By Week VALN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VALN News Sentiment▼0.000.58▲Average Medical News Sentiment VALN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VALN Articles This Week▼05▲VALN Articles Average Week Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IDYA News HRMY News IRON News TARS News BEAM News CNTA News ARQT News ADPT News IMCR News SPRY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VALN) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valneva SE Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Valneva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
